Real-time enrollment status for this fabry disease clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:24 AM UTC
| NCT Number | NCT06904261 |
| Recruiting Status | Recruiting |
| Condition | Fabry Disease |
| Phase | PHASE3 |
| Target Enrollment | 8 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Amicus Therapeutics |
| Last Updated on CT.gov | June 25, 2026 (Jun 25, 2026) |
As of August 28, 2026: Clinical trial NCT06904261 is currently recruiting participants. This phase3 study for fabry disease is actively seeking new participants at 6 locations across the United States. The study is sponsored by Amicus Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06904261 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06904261 was last updated Jun 25, 2026 (June 25, 2026). HelloStudys verifies this status automatically.